Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-13

Clinical Trial Update: Intravenous Tirofiban After Bridging Therapy for Acute Stroke With Atherosclerotic Large Artery Occlusion [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating intravenous tirofiban after bridging therapy for acute ischemic stroke due to atherosclerotic large artery occlusion…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • tirofiban (tirofiban)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Acute Ischemic Stroke | Phase 3 | Status: NOT_YET_RECRUITING